Introduction
A large number of compounds, including bile salts, are transported in the blood bound to protein, particularly albumin, and some are known to share Correspondence: Mr A. Chitranukroh, Academic Department of Medicine, Royal Free Hospital School of Medicine, Rowland Hill Street, London NW3 2PF. common binding sites [l] . Since the binding affinities of bile salts are amongst the lowest reported for albumin ligands [ 1-31 a reduction in the binding of bile salts might be expected as a result of competition for 'albumin-binding sites by other serum components, which are raised in liver disease.
In order to test this hypothesis a simple micropartition centrifugal ultrafiltration technique has been used to monitor the binding of [ glycochenodeoxycholate-3-sulphate in sera from patients with cholestatic liver disease. These bile salts were chosen for the study because glycocholate and glycochenodeoxycholate are the major bile salts of cholestatic serum, whereas glycochenodeoxycholate-3-sulphate is prominent in cholestatic urine and may also be present in the serum [4, 5] .
Materials and methods
Radioactive materials [ 1 -14C] Clycocholate (14C-CC) (specific radioactivity 54 mCi/mmol; 2 x 109Bq/mmol), D-[ 1-l4C]-glucose (50 mCi/mmol; 1.9 x lo9 Bqlmmol) and 3H20 (5 Ci/ml; 18.5 x 10" Bqlml) were purchased from The Radiochemical Centre (Amersham,
Bucks, U.K.). [G-3H]Glycochenodeoxycholate ('H-
GCDC), specific radioactivity 2.3 Cilmmol (8.5 x 10" Bqlmmol), was obtained from New England Nuclear (Boston, MA, U.S.A.). [G-3H]Glycochenodeoxycholate-3-sulphate ('H-GCDCS) (specific radioactivity 8 mCi/mmol; 29.6 x lO'Bq/mmol) was synthesized by Dr T. C. Bartholomew [6] .
Serum samples
Serial serum samples were obtained from patients with benign recurrent intrahepatic chole-stasis (one), cholestatic viral hepatitis (one), extrahepatic cholestasis (one) and chronic active hepatitis (one). They were stored at -20°C until analysed.
Micro-partition system MPS-1
The unbound radioactive bile salts were separated from serum proteins by centrifugal ultrafiltration by using a micro-partition system, MPS-1, from Amicon. The device consists of a sample reservoir with cap (to minimize gas exchange), membrane support base, O-ring, YMB membrane, a set of clips which secure the sample reservoir to the support base and a filtrate collection cup. The serum sample is added to the reservoir and during centrifugation the protein-free ultrafiltrate is collected in the cup.
Procedure
Serum (600 pl), 5 p1 of tracer radioactive bile salt and 5 p l of internal marker were incubated with gentle mixing for 30 min at 37'C.
[ 14C]Glucose was used as the marker for 3H-GCDC and 3H-GCDCS, and 3Hz0 for 14C-GC. The amounts of radioactivity in the incubation mixture were 54.4 nCi (2 x lo3 B ) for 3H-labelled and 4.5 nCi (1.7 x lo2 Bq) for %-labelled compounds. The total amount of bile salt added as tracer was less than 1 nmol/ml of total incubation mixture. Duplicate 200p1 portions of the incubation mixture were then centrifuged at 37°C for 30min at 1500g. Radioactivity was determined in the total ultrafiltrate and in 100 pl of incubation mixture, after the addition of 10 ml of NE 260 scintillation fluid (Nuclear Enterprises, Edinburgh, U.K.). Samples of ultrafiltrate and incubation mixtures that were icteric were decolourized with hydrogen peroxide (100 pl, 300 g/l) and left overnight at 37OC before the addition of scintillant. The vials were counted for radioactivity for 10min in a Philips liquidscintillation spectrometer programmed for doubleisotope counting; quenching was corrected by external standardization.
Calculation
The use of an internal marker to monitor the movement of unbound serum components obviates the need to measure the ultrafiltrate volume, so that the percentage of bound bile salt was calculated as follows:
[ Bile salt in ultrafiltrate (76) = 
100-
Internal marker in ultrafiltrate (%)
Serum bile salts
The total serum 3a-hydroxy bile salt concentration (TSBC) was determined enzymatically [7] after extraction with XAD-7 [8] .
Serum bilirubin
The total serum bilirubin concentration was determined by the method of Jendrassik & Grof [91.
Results
All results were expressed as means 2 SD.
Recovery of isotopes
The recoveries of the radioactive bile salts and markers when added to phosphate/saline buffer (0.1 mol/l), pH 7.4, or serum were evaluated as described in the Materials and methods section, with centrifugation at 1500g for 5 min. In the buffer experiments all the solution was transferred to the filtrate cup, which was weighed and the contents were counted for radioactivity. The recoveries for each set of six experiments, expressed as a percentage of the initial value, were 10022.0% for 14C-GC, 95.3 23.2% for 3H-GCDC and 101.8 22.3% for 3H-GCDCS. The recoveries of the internal markers were 10020.8% for 3Hz0 and 101.5 20.8% for [14C]glucose. Mean values for the ratio of the radioactivity of the tracer bile salt in the ultrafiltrate to that of its marker were 1.0020.02 for I4C-GC, 0.96 20.03 for 3H-GCDC and 1.00 2 0.02 for 3H-GCDCS.
When the isotopes were added to serum the radioactivity of the bile salt and internal marker was determined in both the total ultrafiltrate and the sample remaining in the reservoir and the sum was expressed as the percentage recovery from 2001.11 of incubation mixture. The values for 14C-GC, 3H-GCDC and 3H-GCDCS were 101.32 5.8%, 94.1 k 2.5% and 104.8 k4.0% respectively.
Time of incubation
By monitoring the percentage binding of I4C-GC to normal serum (TSBC = 9 pmol/l) at different times of incubation it was shown that the binding of 14C-GC was maximal after 2min, and was stable over 6 0 min. For convenience the time for subsequent incubations was chosen as 30 min.
Effect of ultrafiltrate volume on protein binding
Different volumes of ultrafiltrate were obtained from 200pl of serum by varying the time of centrifugation. From the estimated values of serum bound 14C-GC it was found that the removal of 1143% of the serum volume as ultrafiltrate did not alter the value for the protein binding of bile salts. The results are shown in Fig. 1 , where each point represents the mean of three consecutive experiments. The experiments were performed with normal serum (TSBC = 9 pmol/l; I4C-GC bound = 75.7 *0.64%; n = 18) and with serum from a patient with liver disease (TSBC=344 jmol/l; 14C-GC bound = 55.1 f 0.60%;n = 18).
The mean volume of ultrafitrate obtained from 200 pl of serum after centrifugation at 1500 g for 30 min was 88.6 k 15.8 pl (n = 60).
Intrabatch and interbatch variation
The reDroducibility of the method was assessed repeated determinations of the percentage binding of 14C-GC, 3H-GCDC and 3H-GCDCS to normal serum (TSBC = 9 pmol/l). Because the percentage binding of 14C-GC was found to be markedly reduced in liver disease, the reproducibility of the binding of this bile salt by cholestatic sera was also determined. In all instances the coefficient of variation was less than 2% (Table 1) .
Normal values
With sera from 12 laboratory staff (eight male, four female) the mean percentages of bound bile salt tracers were 79.9 * 2.6% for 14C-GC, 95.5 * 0.9% for 3H-GCDC and 92.9 * 1.8% for 3H-CCDS.
Patients study
The results of binding studies in four different cases of cholestatic jaundice, i.e. In all patients the binding of 3H-GCDC and 3H-GCDCS remained relatively constant throughout the study but differed for the individuals (Table 2) .
In contrast, marked changes in the binding of 14C-GC were observed, the lowest values occurring when TSBC was maximal. In the cases of benign recurrent intrahepatic cholestasis and viral hepatitis the binding values returned to the normal range when the serum bile acid concentration had normalized. However, in the case of extrahepatic obstruction, which was relieved by biliary drainage [ 111, the percentage binding was still significantly reduced, even when the TSBC had almost returned to normal (25pmol/l). The TSBC in the patient with chronic hepatitis decreased from 410 to 79 pmol/l, whereas the 14C-GC binding rose from 35 to 58%. Relationship between bound 14C-GC and serum total bile salts and bilirubin concentrations -0.76, n = 14, P < 0.001 in benign recurrent intrahepatic cholestasis; r = -0.93, n = 8 , P < 0.001 in chronic active hepatitis;r=-O.93,n = 12, P < 0.001 in extrahepatic obstruction; r = -0.87, n = 10, P < 0.001 in viral hepatitis). There was also a negative correlation between the amount of bound 14C-GC and the serum total bilirubin concentration (r = -0.78, n = 36, P < 0.001) (Fig. 4) .
A negative correlation was obtained between the values in the four patients for bound 14C-GC and those for TSBC (r = -0.62, n = 45, P < 0.001) (Fig. 3) . When the patients were considered individually, a higher correlation was obtained (r = 
Effect of albumin concentrations on 14C-GC binding
The percentage of 14C-GC bound was determined in increasing concentrations (400-1250 /.unol/l) of human serum albumin (Sigma Chemical Co., London) dissolved in sodium phosphate buffer (20 pmol/l), containing NaCl(lO0 mmol/l), pH 7.4. When the binding of I4C-GC was plotted against the concentration of albumin, a hyperbolic saturation curve was attained. The results are shown in Fig. 5 , where the normal ranges of the of conjugated primary bile salts in cholestatic serum, increasing concentrations of glycocholate, glycochenodeoxycholate, taurocholate and taurochenodeoxycholate were added to normal serum and the percentage of bound ''C-GC was estimated. An experiment was also performed with added glycochenodeoxycholate-3-sulphate. The reductions observed were similar for all the bile salts tested (Fig. 6) . The maximum reduction in I4C-GC binding observed at the highest concentration (500pmol/l) of added bile salt amounted to only 5%. Bilirubin. The addition of unconjugated bilirubin in concentrations up to 200 pmolll to normal serum did not cause any reduction in the I4C-GC binding. Fatty acids. Oleic acid and palmitic acid are typical examples of saturated and unsaturated fatty acids which are known to be raised in liver disease [ 121. When added in concentrations of up to 8 0 0~m o l / l , which is greatly in excess of that present in cholestatic serum, neither fatty acid had any effect on I4C-GC binding. Lauric acid, which has been shown to displace tryptophan bound to albumin [13] , also had no effect on the binding of I4C-GC.
Discussion
The binding of bile salts t o serum has been examined by using equilibrium dialysis [2, 
Concn. of added bile salt bmol/l)
by ultrafdtration [ 151 with Centriflo membrane cones (Aminco Corp.). However, this technique requires 3 ml of serum for duplicate determinations and problems have recently been encountered with some batches of cones, which were found to exhibit non-specific binding for bile salts. It is for this reason that the results in this paper differ quantitatively, but not qualitatively, from those presented previously [16] . The micro-partition system used in this study has proved to be a simple and reliable method for the direct determination of bound bile salts in undiluted serum. It is suitable for multiple determinations and can be used with small sample volumes (i.e. 200-300~1). The recoveries of the tracer bile salts from aqueous solutions were greater than 95% in all instances, thereby indicating that non-specific binding was low and indeed for glycocholate and. glycochenodeoxycholate-3-sulphate was almost negligible. The use of internal markers, as advocated by Hammond et al. [17] , eliminated the need to measure the ultrafiltrate volume. Since the values for the ratios of the recoveries for bile salt tracers to those of the internal markers in a protein-free solution approximated to one, it is apparent that the unbound bile salts pass freely through the membrane. The precision of the estimates for the percentage of bound bile salt was not influenced either by the time of incubation or the ultrafitrate volume. This technique therefore has considerable potential for physiological studies involving hepatic, renal and intestinal transport in which the relative importance of free and bound bile acids is still debatable.
The mean results obtained in control subjects for the binding of the two main primary bile salts 14C-GC (79.9 f 2.6%) and 3H-GCDC (95.5 f 0.9%) were of the same order as those previously reported from ultrafdtration with cones [15, 181. There has been no previous report on conjugated chenodeoxycholate sulphates; the mean value of 92.9 f 1.8% for 3H-GCDCS was, however, similar t o that reported for chenodeoxycholate sulphate [ 181.
In liver disease serial determinations showed that the binding of 3H-GCDC and 3H-GCDCS was relatively unchanged during the course of the illness, although the absolute values tended t o be somewhat lower than those given by the control subjects and reductions of up to 10% for 3H-GCDC and 5% for 3H-GCDCS were noted; these changes were not related to the albumin concentration of the serum. The reductions in the binding of I4C-GC were very much greater (Fig. 2 ) and were shown to be inversely related to the total 3a-hydroxy bile salt concentration (Fig. 3) . However, when a high concentration (500 pmol/l) of glyco-cholate, glycochenodeoxycholate or glycochenodeoxycholate-3-sulphate was added to normal serum the reduction in I4C-GC binding amounted to only 5% of the initial value (Fig. 6) , which was markedly less than that seen in the patients. Since these bile salts would account for 90% or more of the total bile salts in cholestatic serum [5] , it is unlikely that the reduction in 14C-GC binding is due to the raised concentration of serum total bile salts, which is merely an index of the degree of cholestasis.
The marked changes in the percentages of 14C-GC bound, when compared with the relatively constant binding of 3H-GCDC and 'H-GCDCS, in cholestatic liver disease could be explained by the lower binding affinity of glycocholate for albumin [ 191. The finding that 14C-GC binding was reduced to a similar extent by added concentrations of glycocholate, glycochenodeoxycholate or glycochenodeoxycholate-3-sulphate (Fig. 6 ) suggests, however, that glycocholate has binding sites on the albumin molecule which are not shared by glycochenodeoxycholate or glycochenodeoxycholate-3-sulphate.
An inverse correlation (Fig. 4) wasalso observed between the 14C-GC binding and serum total bilirubin. The serum pigments in the patients studied were predominantly bilirubin conjugates, as judged by the diazo reaction. Pure specimens of bilirubin glucuronide were not, unfortunately, available in sufficient amounts for study, so it is not known if they interfere with bile salt binding. In contrast with the findings of Roda et al. [20] the addition of unconjugated bilirubin to normal serum had no effect on 14C-GC binding, so this cannot be invoked as a causative factor.
No evidence was obtained that the raised concentration of free fatty acids found in patients with liver disease [12, 211 is responsible for the reduction in 14C-GC binding. It therefore seems likely that the reduction in the binding of 14C-GC is due to competition for albumin binding sites by compounds other -than bile salts, unconjugated bilirubin or fatty acids. The variable extent of the reduction in the 14C-GC binding seen could be taken as an index of the amounts of such compounds in cholestatic sera. Further investigations are therefore necessary t o determine their identity. The effect of changes in the conformation of the albumin molecule [22] on the binding of 14C-GC in cholestatic serum cannot, however, be excluded.
